# NGNE (Neurogene Inc.) - SEC EDGAR Financial Statements

> Neurogene Inc. reported $0 in revenue and a net loss of $119.2M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/NGNE
- Markdown: https://convexityos.com/fundamentals/NGNE.md
- SEC CIK: 0001404644
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:38 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001404644&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | -100.0% YoY |
| Operating Income | FY 2025 | -$129.9M | Operating profit |
| Net Income | FY 2025 | -$119.2M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$4.30 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$97.53M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $359.7M | Total debt: $7.55M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $925K | $0 | -- | -- | -- | -- | $25.00M | -- | -- |
| Research & Development | $75.01M | $60.92M | $44.39M | $47.51M | $39.16M | $24.34M | $4.42M | $41.79M | $36.27M | $28.38M |
| Total Operating Expenses | $103.3M | $83.53M | $55.58M | $56.52M | $60.70M | -- | $70.96M | $57.62M | $51.12M | $37.65M |
| **Operating Income** | -$103.3M | -$82.61M | -$55.58M | -$56.52M | -$60.70M | -$33.73M | -$70.96M | -$32.62M | -$51.12M | -$37.65M |
| **EBITDA** | -$100.3M | -$79.41M | -$52.32M | -$53.32M | -$59.39M | -$32.94M | -$70.62M | -$32.34M | -$50.76M | -- |
| Interest Income | $11.55M | $8.47M | $2.95M | $1.34M | -- | -- | -- | -- | -- | -- |
| Interest Expense | $5.0K | $12K | $12K | $2.0K | -- | -- | $1.0K | $4.0K | $4.0K | $1.0K |
| Income Before Tax | -$90.35M | -$75.14M | -$36.32M | -$55.19M | -$60.69M | -$33.28M | -$69.44M | -$31.59M | -$50.18M | -$37.00M |
| Income Tax Expense | $0 | $0 | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Net Income** | -$90.35M | -$75.14M | -$36.32M | -$55.19M | -$60.69M | -$33.28M | -$69.44M | -$31.59M | -$50.18M | -$37.00M |
| Basic EPS | -$4.24 | -$4.28 | -- | -$20.80 | -$22.00 | -$12.80 | -$51.40 | -$26.80 | -$42.80 | -$39.20 |
| **Diluted EPS** | -$4.24 | -$4.28 | -- | -$20.80 | -$22.00 | -$12.80 | -$51.40 | -$26.80 | -$42.80 | -$39.20 |
| Basic Shares Outstanding | 21.3M | 17.6M | -- | 2.8M | 2.8M | 2.6M | 1.4M | 1.2M | 1.2M | 944.7K |
| Diluted Shares Outstanding | 21.3M | 17.6M | -- | 2.8M | 2.8M | 2.6M | 1.4M | 1.2M | 1.2M | 944.7K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | $0 | $0 | -- | -- |
| Research & Development | $23.52M | $25.47M | $25.15M | $20.64M | $17.24M | $19.37M | $17.76M | $15.35M |
| Total Operating Expenses | $32.38M | $36.67M | $33.35M | $27.53M | $23.80M | $26.08M | $25.92M | $21.51M |
| **Operating Income** | -$32.38M | -$36.67M | -$33.35M | -$27.53M | -$23.80M | -$26.08M | -$25.92M | -$21.51M |
| **EBITDA** | -$31.55M | -$35.86M | -$32.50M | -$26.75M | -$23.00M | -$25.28M | -$25.17M | -$20.73M |
| Interest Income | $3.24M | $2.05M | $2.26M | $2.67M | $2.74M | $2.93M | $3.21M | $2.27M |
| Interest Expense | $0 | $0 | $0 | $1.0K | $1.0K | $1.0K | $2.0K | $2.0K |
| **Net Income** | -$29.02M | -$34.49M | -$30.93M | -$24.73M | -$20.95M | -$22.02M | -$22.65M | -$19.51M |
| Basic EPS | -$1.05 | -$1.53 | -$1.39 | -- | -$0.99 | -$1.05 | -$1.08 | -- |
| **Diluted EPS** | -$1.05 | -$1.53 | -$1.39 | -- | -$0.99 | -$1.05 | -$1.08 | -- |
| Basic Shares Outstanding | 27.7M | 22.6M | 22.3M | -- | 21.2M | 21.1M | 21.0M | -- |
| Diluted Shares Outstanding | 27.7M | 22.6M | 22.3M | -- | 21.2M | 21.1M | 21.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $103.8M | $136.6M | $148.2M | $82.02M | $142.5M | $192.6M | $143.1M | $76.93M | $52.03M | $32.30M |
| Short-Term Investments | $165.2M | $175.8M | $48.95M | $0 | $0 | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $269.0M | $312.4M | $197.2M | $82.02M | $142.5M | $192.6M | $143.1M | $76.93M | $52.03M | $32.30M |
| Other Current Assets | $168K | $981K | $1.09M | $630K | $1.52M | $1.97M | $503K | -- | -- | -- |
| **Total Current Assets** | $271.8M | $315.9M | $200.3M | $84.72M | $144.0M | $194.5M | $143.6M | $77.17M | $108.8M | $103.5M |
| Property, Plant & Equipment, Net | $12.79M | $15.42M | $17.17M | $20.11M | $6.45M | $3.57M | $2.06M | $400K | $905K | $849K |
| Intangible Assets | -- | -- | -- | $0 | $128K | $347K | $567K | -- | -- | -- |
| Other Non-Current Assets | $1.03M | $975K | $764K | $0 | $1.93M | $1.93M | $30K | -- | -- | -- |
| **Total Non-Current Assets** | $16.83M | $19.81M | $22.23M | $24.55M | $19.27M | $16.00M | $3.43M | $453K | $1.50M | $50.90M |
| **Total Assets** | $288.6M | $335.7M | $222.6M | $109.3M | $163.3M | $210.5M | $147.0M | $77.62M | $110.3M | $154.4M |
| Accounts Payable | $1.95M | $1.34M | $2.60M | $625K | $526K | $1.32M | $1.60M | $702K | $6.02M | $6.86M |
| Other Current Liabilities | $564K | $342K | $737K | $167K | -- | -- | -- | -- | $720K | $254K |
| **Total Current Liabilities** | $16.41M | $15.16M | $22.97M | $6.65M | $8.64M | $7.89M | $4.74M | $4.63M | $10.96M | $9.52M |
| Other Non-Current Liabilities | $51K | $51K | $203K | $0 | -- | -- | -- | $319K | $486K | $197K |
| **Total Non-Current Liabilities** | $7.31M | $10.20M | $13.58M | $3.99M | $11.76M | $11.41M | $593K | $319K | $486K | $197K |
| **Total Liabilities** | $23.72M | $25.36M | $36.55M | $10.64M | $20.40M | $19.30M | $5.34M | $4.95M | $11.44M | $9.72M |
| **Total Debt (incl. Leases)** | $9.89M | $12.43M | $14.97M | $4.69M | $12.98M | $12.12M | $1.21M | $15K | -- | -- |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$352.6M | -$262.3M | -$187.2M | -$150.8M | -$393.5M | -$332.8M | -$299.5M | -$230.1M | -$198.5M | -$148.3M |
| Accumulated Other Comp. Income | -- | -- | -- | -$21K | $0 | -- | -- | -- | -$70K | -$169K |
| **Total Stockholders' Equity** | $264.9M | $310.4M | $186.0M | -$145.7M | -$91.88M | $191.2M | $141.7M | $72.67M | $98.89M | $144.7M |
| Total Equity | $264.9M | $310.4M | $186.0M | -$145.7M | -$91.88M | $191.2M | $141.7M | $72.67M | $98.89M | $144.7M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $78.94M | $112.5M | $124.2M | $103.8M | $71.00M | $58.81M | $70.77M | $136.6M |
| Short-Term Investments | $280.8M | $112.9M | $119.0M | $165.2M | $194.4M | $215.7M | $221.8M | $175.8M |
| **Cash & Short-Term Investments** | $359.7M | $225.4M | $243.2M | $269.0M | $265.4M | $274.5M | $292.6M | $312.4M |
| Other Current Assets | $122K | $132K | $181K | $168K | $208K | $970K | $997K | $981K |
| **Total Current Assets** | $362.7M | $228.9M | $246.7M | $271.8M | $270.5M | $279.0M | $296.4M | $315.9M |
| Property, Plant & Equipment, Net | $11.19M | $11.73M | $12.50M | $12.79M | $13.48M | $14.25M | $14.81M | $15.42M |
| Other Non-Current Assets | $1.57M | $1.11M | $1.08M | $1.03M | $1.06M | $1.10M | $896K | $975K |
| **Total Non-Current Assets** | $15.16M | $15.45M | $16.39M | $16.83M | $17.31M | $18.33M | $18.90M | $19.81M |
| **Total Assets** | $377.9M | $244.4M | $263.1M | $288.6M | $287.8M | $297.3M | $315.3M | $335.7M |
| Accounts Payable | $2.29M | $3.29M | $4.68M | $1.95M | $1.54M | $2.06M | $3.06M | $1.34M |
| Other Current Liabilities | $612K | $1.08M | $947K | $564K | $327K | $359K | $745K | $342K |
| **Total Current Liabilities** | $18.16M | $21.50M | $18.87M | $16.41M | $14.71M | $15.44M | $14.09M | $15.16M |
| Other Non-Current Liabilities | $0 | $0 | $0 | $51K | $51K | $51K | $51K | $51K |
| **Total Non-Current Liabilities** | $4.94M | $5.73M | $6.49M | $7.31M | $7.58M | $8.62M | $9.41M | $10.20M |
| **Total Liabilities** | $23.11M | $27.23M | $25.36M | $23.72M | $22.29M | $24.06M | $23.51M | $25.36M |
| **Total Debt (incl. Leases)** | $7.55M | $8.35M | $9.13M | $9.89M | $10.21M | $10.97M | $11.71M | $12.43M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$447.1M | -$418.1M | -$383.6M | -$352.6M | -$327.9M | -$307.0M | -$284.9M | -$262.3M |
| **Total Stockholders' Equity** | $354.8M | $217.1M | $237.8M | $264.9M | $265.5M | $273.3M | $291.8M | $310.4M |
| Total Equity | $354.8M | $217.1M | $237.8M | $264.9M | $265.5M | $273.3M | $291.8M | $310.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$90.35M | -$75.14M | -$36.32M | -$55.19M | -$60.69M | -$33.28M | -$69.44M | -$31.59M | -$50.18M | -$37.00M |
| Depreciation & Amortization | $3.04M | $3.19M | $3.26M | $3.20M | $1.31M | $785K | $340K | $289K | $360K | -- |
| Stock-Based Compensation | $14.18M | $8.32M | $1.42M | $1.25M | $11.56M | $5.62M | $7.68M | $4.70M | $3.84M | $1.97M |
| Change in Payables | $627K | -$77K | $667K | -$3.61M | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$77.17M | -$70.60M | -$51.42M | -$52.82M | -$47.56M | -$24.57M | -$15.39M | -$31.58M | -$44.72M | -$30.23M |
| Capital Expenditure | -$1.18M | -$808K | -$321K | -$2.23M | -$3.26M | -$2.22M | -$879K | -$49K | -$494K | -$713K |
| **Free Cash Flow** | -$78.36M | -$71.41M | -$51.74M | -$55.05M | -$50.82M | -$26.79M | -$16.27M | -$31.63M | -$45.21M | -$30.94M |
| Purchases of Investments | -- | -- | -- | -$107.5M | $0 | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $14.00M | -$125.3M | $25.64M | -$2.23M | -$3.26M | -$2.22M | -$688K | $55.95M | $64.01M | -$48.06M |
| Common Stock Issued | $30.38M | $0 | $92.34M | $0 | $0 | $71.67M | $81.04M | -- | -- | $75.37M |
| **Financing Cash Flow** | $30.43M | $184.1M | $92.48M | $66.53M | $732K | $77.14M | $82.24M | $570K | $423K | $71.11M |
| **Net Change in Cash** | -$32.74M | -$11.79M | $66.70M | $11.48M | -$50.09M | $50.34M | $66.17M | $24.90M | $19.73M | -$7.22M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$29.02M | -$34.49M | -$30.93M | -$24.73M | -$20.95M | -$22.02M | -$22.65M | -$19.51M |
| Depreciation & Amortization | $821K | $813K | $847K | $776K | $800K | $800K | $749K | $785K |
| Stock-Based Compensation | $5.15M | $7.86M | $3.63M | $3.36M | $3.37M | $3.41M | $4.05M | $2.49M |
| Change in Payables | -$979K | -$1.12M | $2.42M | $409K | -$501K | -$975K | $1.69M | -$416K |
| **Operating Cash Flow** | -$29.14M | -$23.76M | -$26.12M | -$17.43M | -$19.51M | -$19.46M | -$20.77M | -$17.50M |
| Capital Expenditure | -$315K | -$354K | -$281K | -$128K | -$127K | -$148K | -$780K | -$116K |
| **Free Cash Flow** | -$29.46M | -$24.11M | -$26.40M | -$17.56M | -$19.64M | -$19.61M | -$21.55M | -$17.61M |
| **Investing Cash Flow** | -$166.0M | $6.10M | $46.24M | $29.61M | $21.99M | $7.45M | -$45.05M | -$102.6M |
| **Financing Cash Flow** | $161.6M | $5.98M | $195K | $20.66M | $9.71M | $54K | $4.0K | $190.1M |
| **Net Change in Cash** | -$33.54M | -$11.68M | $20.32M | $32.84M | $12.19M | -$11.96M | -$65.81M | $69.95M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -8930.3% | -- | -- | -- | -- | -- | -130.5% | -- | -- |
| **Net Profit Margin** | -- | -8123.7% | -- | -- | -- | -- | -- | -126.3% | -- | -- |
| Return on Equity (ROE) | -34.1% | -24.2% | -19.5% | -- | -- | -17.4% | -49.0% | -43.5% | -50.7% | -25.6% |
| Return on Assets (ROA) | -31.3% | -22.4% | -16.3% | -50.5% | -37.2% | -15.8% | -47.2% | -40.7% | -45.5% | -24.0% |
| Current Ratio | 16.56x | 20.84x | 8.72x | 12.74x | 16.67x | 24.66x | 30.28x | 16.68x | 9.93x | 10.87x |
| Quick Ratio | 16.39x | 20.61x | 8.58x | 12.33x | 16.50x | 24.41x | 30.17x | 16.63x | 4.75x | 3.39x |
| Debt to Equity | 0.04x | 0.04x | 0.08x | -- | -- | 0.06x | 0.01x | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | -100.0% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -33.6% | -51.2% | -41.5% | -34.1% | -32.1% | -30.9% | -27.7% | -24.2% |
| Return on Assets (ROA) | -31.5% | -45.5% | -37.5% | -31.3% | -29.6% | -28.4% | -25.6% | -22.4% |
| Current Ratio | 19.97x | 10.64x | 13.08x | 16.56x | 18.39x | 18.07x | 21.03x | 20.84x |
| Quick Ratio | 19.80x | 10.48x | 12.89x | 16.39x | 18.04x | 17.78x | 20.76x | 20.61x |
| Debt to Equity | 0.02x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -100.0% | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -918.9% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
